Cancer Screening Applications
-
Researchers - FIRE—Blazing a New Trail in Guided Surgery and Diagnostics
Cancer-targeted molecular probes have the potential to revolutionize surgery and diagnostics. Offering unparalleled flexibility and outstanding performance, FIRE epitomizes the cutting edge of this technology. FIRE’s quenched, substrate-based probe (qSBP) technology guides surgeons by ensuring probe signal is only seen when cancer is detected, clearly delineating tumor tissue from healthy tissue and virtually eliminating spurious background fluorescence common in other probes. ...
By Akrotome Imaging, Inc. based in Cleveland, OHIO (USA).
-
Patients - Getting It All – Better Cancer Resections with FIRE – Guided Surgery
The Promise: With modern diagnostic and imaging technologies, cancer can be detected earlier than ever before. And with earlier detection comes the promise of a surgical cure—that is, the complete removal (or resection) of all tumor tissue from a patient. Research has shown that patients with surgical cures have fewer complications in recovery and a greatly enhanced survival rate when compared to patients who do not achieve surgical ...
By Akrotome Imaging, Inc. based in Cleveland, OHIO (USA).
-
Automation of molecular pathology
Tumor markers found in blood, urine and body tissues can be used in diagnosing and treating cancer. Each tumor marker is indicative of a particular disease and thus can be used for the screening, monitoring and diagnosis of specific tumor types. In addition to being used in prognosis, these molecular markers help to predict the response, resistance and toxicity to therapy. For example, BCR-ABL gene sequence detection is used to diagnose chronic myelogenous leukemia and acute lymphatic ...
By Aurora Biomed Inc. based in Vancouver, BRITISH COLUMBIA (CANADA).
-
PTR-MS systems for medical applications
PTR-MS are powerful tools for non-invasive, real-time breath gas analysis with many applications, such as screening for disease markers, study of pharmacokinetics or metabolic ...
By Ionicon Analytik Ges.m.b.H. based in Innsbruck, AUSTRIA.
-
IGX Platform Software for Cancer Vaccines
Unlike conventional vaccination strategies, cancer vaccines are designed to mount responses against tumor-specific antigens, arising from somatic mutations specific to the cancer genome. They promise a highly tailored approach by targeting patient-specific ...
By Enpicom B.V. based in s-Hertogenbosch, NETHERLANDS.
-
Partial Mastectomy - How MarginProbe® Can Help
Partial mastectomy is another name for a lumpectomy, a breast-conserving surgery that only removes the part of the breast that has cancer and a small rim around it to help prevent ...
By Dilon Technologies Inc. based in Newport News, VIRGINIA (USA).
-
Zenalux Technology in Pre-clinical and Clinical Applications
Zenalux technology has been applied to the quantitative optical analysis of tissues in a number of published studies in both pre-clinical models and in patients. In the breast, the Zenalux technology has been proven to be sensitive to sources of intrinsic optical contrast, in particular, hemoglobin, beta carotene and scattering which effectively discriminate diseased from healthy tissues (see Published Papers.) ...
By Zenalux Biomedical, Inc. based in Durham, NORTH CAROLINA (USA).
-
Actionable Molecular Diagnostic System for Physicians
Providing physicians with innovative and meaningful assays for the earlier detection of clinically significantly prostate ...
By MDxHealth based in Irvine, CALIFORNIA (USA).
-
IQ-Tip System for Patients
Precision means caring, and gives confidence to both patient and physician in times when lumbar puncture is a necessity. Less traumatic punctures may reduce unnecessary chemotherapy of the patient, and in the long term, it may reduce the risk of secondary cancers later in early adulthood. This can save costs now and in the ...
By Injeq Oy based in Tampere, FINLAND.
-
Fluorescence Imaging Solutions for Clinical Trials
Pegloprastide (also known as AVB-620) has completed a Phase 2 registration trial for fluorescent detection of cancer during breast cancer surgery (NCT03113825), as well as a Phase 1b clinical trial in women undergoing breast cancer surgery ...
By Avelas Biosciences based in La Jolla, CALIFORNIA (USA).
-
Diagnostic Tests Kit for Bladder Cancer
Bladder cancer is the seventh most common cancer diagnosis in worldwide, with 500 000 new cases and 200 000 deaths in 2018 (Globocan 2018). More than 2.7 million people have a history of bladder cancer worldwide. At the initial diagnosis of bladder cancer, more than 80% of cases are diagnosed as non-muscle-invasive bladder cancer (NMIBC). Due to the very high recurrence rate (>80%), NMIBC patients require lifelong surveillance with periodic follow-up cystoscopy (an unpleasant invasive exam) and urine cytology ...
By OncoDiag based in Miserey, FRANCE.
-
Diagnostic Tests Kit for Prostate Cancer
Prostate cancer is the fourth most common cancer diagnosis in worldwide, with 1 300 000 new cases and 360 000 deaths in 2018 (Globocan 2018). At the initial diagnosis the disease, more than 60% of cases are diagnosed as localized prostate cancer. Localized prostate cancer can be asymptomatic at the early stage and often has an indolent course that may require only active surveillance. Indolent or aggressive, to treat or not to treat this cancer? This is always the question urologists ask themselves. ...
By OncoDiag based in Miserey, FRANCE.
-
Breast MRI System for Breast Cancer
Cancer is a group of diseases in which normal cells change and grow out of control. In breast cancer, the cancerous cells are usually cells of the lobules and ducts (ie, the glands that produce milk and the channels that carry milk to the nipple). Keep in mind that cancer, or carcinoma, of the breast can be broadly divided into two categories : ...
By Aurora Healthcare US Corp. based in Danvers, MASSACHUSETTS (USA).
-
Genomic Workbench Software for Cancer Biology
Cancer is one of the leading causes of deaths in India and a major public health concern. It is estimated that there are around 1 million new cancer cases every year and as many as 5 lakh deaths occur annually. Around 71% of all cancer deaths in India occur in people 30 to 69 years of age, when adults are very productive. The burden of cancer is expected to further increase due to increase in life expectancy, heavy use of tobacco and other risk factors such as radiation, viruses, ...
By inDNA Research Labs based in INDIA.
-
Proteome array screening solutions for autoantibody screening sector
Discover autoantigens in autoimmune diseases, delineate new candidate biomarkers. Autoantibodies are present in the blood of all healthy individuals. However, when directed at high levels against protein targets in specific tissues, autoantibodies can be a major cause of autoimmune diseases. They are also important biomarkers for diagnosis of these conditions. ...
By Cambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM.
-
Diagnostic Solutions for Colorectal Cancer
Standard treatment for advanced colorectal cancer generally involves surgical resection and chemotherapy. However, the recent emergence of targeted therapies, particularly those that inhibit EGFR, has provided treatment options that extend survival for a subset of patients. Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. This makes characterizing these molecular markers an ...
By Biocept based in San Diego, CALIFORNIA (USA).
-
Diagnostic solutions for multiplexing sector
Multiplexing is the ability to identify a broad spectrum of conditions in a single molecular diagnostic test procedure, as opposed to conducting discrete individual procedures. It enables a single test to identify numerous conditions, attributes, or genetic sequences simultaneously, including those belonging to: cancer genes; a bacteria or virus in humans, animals or the food distribution supply chain, or specific attributes of a seed ...
By Co-Diagnostics, Inc. based in Salt Lake City, UTAH (USA).
-
Highly customized aptamer discovery solutions for aptamers in neurological disease sector
More than 5 million people in the United States and an estimated 50 million people worldwide are living with Alzheimer’s disease. More than 10 million people worldwide are living with Parkinson’s. Brain tumors and tumors of the central nervous system are the most common form of cancer in children under 19 and the leading cause of cancer-related deaths in children under 14 in the U.S. While antibody drugs have made great strides in cancer therapies, crossing the blood-brain barrier (BBB) and ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
-
Pipeline for Immuno-Oncology
AlNovo is pioneering new therapeutic modalities based on our Novobinder Platform to harness the power of the human immune system to directly attack cancer ...
By Ainovo Biotech Inc. based in Sacramento, CALIFORNIA (USA).
-
Fusion - Bx - Semi-Robotic Arm System for Patients
The prostate is a gland in the male reproductive system. About the size of a ping-pong ball, it is located just below the bladder and in front of the rectum. The gland surrounds the urethra, the tube that carries urine and semen through the penis. It contains several small glands, whose main purpose is to produce the milky white part of semen. This super fluid acts as a vehicle protecting your sperm during the big ...
By Focal Healthcare based in Toronto, ONTARIO (CANADA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you